MEDIUM confidence: 100% data completeness, but the composite (37) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $2.2B— | $2.5B+11.0% | $2.2B-10.5% | $2.4B+9.4% | $2.9B+19.0% |
| EPS (dil.) | $0.50— | $0.91+82.0% | $-0.18-119.8% | $0.54n/m | $1.68+211.1% |
| Free Cash Flow | $95M— | $170M+79.5% | $27M-84.1% | $51M+89.2% | -$683K-101.3% |
| Gross Margin | 16.5% | 18.4%+1.8pp | 18.5%+0.2pp | 19.5%+1.0pp | 19.6%+0.0pp |
| Operating Margin | 5.6% | 8.4%+2.8pp | 1.9%-6.5pp | 4.8%+2.9pp | 9.0%+4.3pp |
| Net Margin | 2.4% | 3.8%+1.4pp | -0.8%-4.6pp | 2.3%+3.1pp | 6.1%+3.8pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 33.1%/yr (revenue basis).
Base free cash flow $26M (avg FY2023–FY2025; latest year -$683000) · equity value $8.7B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Avg target $183 (last qtr, 6 analysts) → $185 (last mo, 5) (+0.9%).
Buy-rated share 100% → 100% over ~3 months (+0pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Oct 2026 | $1.25 | $1.46 | +16.8% |
| Aug 2026 | $0.89 | $0.99 | +10.7% |
| Apr 2026 | $0.66 | $0.75 | +13.6% |
| Feb 2026 | $0.68 | $0.70 | +2.9% |
| Oct 2025 | $0.61 | $0.67 | +9.8% |
| Jul 2025 | $0.52 | $0.58 | +11.5% |
| Apr 2025 | $0.39 | $0.50 | +28.2% |
| Feb 2025 | $0.47 | $0.60 | +27.7% |
Net insider -$4.2M over 180 days (5 open-market buys, 93 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 37 for TTM Technologies indicates a neutral outlook, with the stock's value score being a relative bright spot, driven by a P/E of 32.3 and P/S of 2.3. However, the momentum score is dragged down by a sharp 3-month decline of 31.6% and a bearish moving average crossover. The long-term and short-term scores diverge by 7 points, with the long-term score being slightly higher at 41, suggesting some potential for rebound. The stock's high beta of 2.1 and significant 60-day volatility of 101.3% contribute to its low risk score.